{"count": 4, "results": [{"_id": "40465795", "pmid": 40465795, "title": "Identification of potentially effective drugs for metabolic dysfunction-associated steatotic liver disease against liver cirrhosis: In-silico drug repositioning-based retrospective cohort study.", "journal": "PLoS One", "authors": ["Lee CW", "Kang ES", "Jeong S", "Han HW"], "date": "2025-06-04T00:00:00Z", "doi": "10.1371/journal.pone.0323880", "meta_date_publication": "2025", "meta_volume": "20", "meta_issue": "6", "meta_pages": "e0323880", "score": 50248.867, "text_hl": "Identification of potentially effective drugs for @DISEASE_Liver_Diseases @DISEASE_MESH:D008107 @@@metabolic dysfunction-associated steatotic liver disease@@@ against @<m>DISEASE_Liver_Cirrhosis</m> @DISEASE_MESH:D008103 @@@liver cirrhosis@@@: In-silico drug repositioning-based retrospective cohort study.", "citations": {"NLM": "Lee CW, Kang ES, Jeong S, Han HW. Identification of potentially effective drugs for metabolic dysfunction-associated steatotic liver disease against liver cirrhosis: In-silico drug repositioning-based retrospective cohort study. PLoS One. 2025;20(6):e0323880. PMID: 40465795", "BibTeX": "@article{40465795, title={Identification of potentially effective drugs for metabolic dysfunction-associated steatotic liver disease against liver cirrhosis: In-silico drug repositioning-based retrospective cohort study.}, author={Lee CW and Kang ES and Jeong S and Han HW}, journal={PLoS One}, volume={20}, number={6}, pages={e0323880}}"}}, {"_id": "2658555", "pmid": 2658555, "title": "Atenolol for prevention of rebleeding from esophageal varices in hepatic cirrhosis: results of a controlled, randomized pilot study.", "journal": "Am J Gastroenterol", "authors": ["Bonkovsky HL", "Bonkovsky ML", "Anderson PB", "Rothstein RI", "Erkkinen JF"], "date": "1989-06-01T00:00:00Z", "meta_date_publication": "1989 Jun", "meta_volume": "84", "meta_issue": "6", "meta_pages": "681-3", "score": 50065.52, "text_hl": "@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ for prevention of rebleeding from @DISEASE_Esophageal_and_Gastric_Varices @DISEASE_MESH:D004932 @@@esophageal varices@@@ in @<m>DISEASE_Liver_Cirrhosis</m> @DISEASE_MESH:D008103 @@@hepatic cirrhosis@@@: results of a controlled, randomized pilot study.", "citations": {"NLM": "Bonkovsky HL, Bonkovsky ML, Anderson PB, Rothstein RI, Erkkinen JF. Atenolol for prevention of rebleeding from esophageal varices in hepatic cirrhosis: results of a controlled, randomized pilot study. Am J Gastroenterol. 1989 Jun;84(6):681-3. PMID: 2658555", "BibTeX": "@article{2658555, title={Atenolol for prevention of rebleeding from esophageal varices in hepatic cirrhosis: results of a controlled, randomized pilot study.}, author={Bonkovsky HL and Bonkovsky ML and Anderson PB and Rothstein RI and Erkkinen JF}, journal={Am J Gastroenterol}, volume={84}, number={6}, pages={681-3}}"}}, {"_id": "1896818", "pmid": 1896818, "title": "The effects of selective and non-selective adrenoceptor blockade on the portal blood flow in patients with liver cirrhosis.", "journal": "Scand J Gastroenterol", "authors": ["Ljubicić N", "Bilić A"], "date": "1991-07-01T00:00:00Z", "doi": "10.3109/00365529108998595", "meta_date_publication": "1991 Jul", "meta_volume": "26", "meta_issue": "7", "meta_pages": "751-7", "score": 50062.066, "text_hl": "The effects of selective and non-selective adrenoceptor blockade on the portal blood flow in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Liver_Cirrhosis</m> @DISEASE_MESH:D008103 @@@liver cirrhosis@@@.", "citations": {"NLM": "Ljubicić N, Bilić A. The effects of selective and non-selective adrenoceptor blockade on the portal blood flow in patients with liver cirrhosis. Scand J Gastroenterol. 1991 Jul;26(7):751-7. PMID: 1896818", "BibTeX": "@article{1896818, title={The effects of selective and non-selective adrenoceptor blockade on the portal blood flow in patients with liver cirrhosis.}, author={Ljubicić N and Bilić A}, journal={Scand J Gastroenterol}, volume={26}, number={7}, pages={751-7}}"}}, {"_id": "8179835", "pmid": 8179835, "pmcid": "PMC3053877", "title": "Hyperkalemia due to hyporeninemic hypoaldosteronism with liver cirrhosis and hypertension.", "journal": "J Korean Med Sci", "authors": ["Kee CS", "Choi JW", "Chang DK", "Ahn YH", "Kim HJ"], "date": "1993-12-01T00:00:00Z", "doi": "10.3346/jkms.1993.8.6.464", "meta_date_publication": "1993 Dec", "meta_volume": "8", "meta_issue": "6", "meta_pages": "464-70", "score": 50050.87, "text_hl": "A 49-year-old man with @<m>DISEASE_Liver_Cirrhosis</m> @DISEASE_MESH:D008103 @@@liver cirrhosis@@@ and @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ was found to have @DISEASE_Hyperkalemia @DISEASE_MESH:D006947 @@@hyperkalemia@@@ out of a degree of @DISEASE_Renal_Insufficiency @DISEASE_MESH:D051437 @@@renal insufficiency@@@ and @DISEASE_Acidosis @DISEASE_MESH:D000138 @@@metabolic acidosis@@@ with low to normal anion gap, aggravated by @DISEASE_Crisponi_syndrome @DISEASE_MESH:C536214 @@@volume contraction@@@ with @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhea@@@ and medications (@CHEMICAL_Captopril @CHEMICAL_MESH:D002216 @@@captopril@@@, @CHEMICAL_Spironolactone @CHEMICAL_MESH:D013148 @@@spironolactone@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@) interfering with @CHEMICAL_Potassium @CHEMICAL_MESH:D011188 @@@potassium@@@ homeostasis. ", "citations": {"NLM": "Kee CS, Choi JW, Chang DK, Ahn YH, Kim HJ. Hyperkalemia due to hyporeninemic hypoaldosteronism with liver cirrhosis and hypertension. J Korean Med Sci. 1993 Dec;8(6):464-70. PMID: 8179835", "BibTeX": "@article{8179835, title={Hyperkalemia due to hyporeninemic hypoaldosteronism with liver cirrhosis and hypertension.}, author={Kee CS and Choi JW and Chang DK and Ahn YH and Kim HJ}, journal={J Korean Med Sci}, volume={8}, number={6}, pages={464-70}}"}}]}